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Abstract
Background: Most studies of Attention-deficit hyperactivity disorder (ADHD) have focused on
either young children or older adults. The current study compared 11 ADHD adolescents with 12
age-matched controls. The purpose was to examine differences in dietary intake, particularly of
essential fatty acids, and determine whether this could explain the typical abnormalities in red blood
cell fatty acids observed in previous studies of young children. A secondary purpose was to
determine if there were relationships between circulating concentrations of essential fatty acids and
specific ADHD behaviours as measured by the Conners' Parent Rating Scale (CPRS-L).
Methods: Eleven ADHD adolescents and twelve age-matched controls were recruited through
newspaper ads, posters and a university website. ADHD diagnosis was confirmed by medical
practitioners according to DSM-IV criteria. Blood, dietary intake information as well as behavioural
assessments were completed.
Results: Results showed that ADHD adolescents consumed more energy and fat than controls
but had similar anthropometry. ADHD children consumed equivalent amounts of omega-3 and
omega-6 fatty acids to controls, however they had significantly lower levels of docosahexaenoic
acid (DHA, 22:6n-3) and total omega-3 fatty acids, higher omega-6 fatty acids and a lower ratio of
n-3:n-6 fatty acids than control subjects. In addition, low omega-3 status correlated with higher
scores on several Conners' behavioural scales.
Conclusion: These data suggest that adolescents with ADHD continue to display abnormal
essential fatty acid profiles that are often observed in younger children and distinctly different from
normal controls of similar age. Further these red blood cell fatty acid differences are not explained
by differences in intake. This suggests that there are metabolic differences in fatty acid handling
between ADHD adolescents and normal controls. The value of omega-3 supplements to improve
fatty acid profiles and possibly behaviours associated with ADHD, need to be examined.
Background
Attention deficit hyperactivity disorder (ADHD) is prima-
rily characterized by a "persistent pattern of inattention
and/or hyperactivity-impulsivity that is more frequent
and severe than is typically observed in individuals at a
comparable level of development" [1,2]. The American
Psychiatric Association estimates that 3–5% of school
aged children have ADHD (DSM-IV), while other sources
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report higher prevalence rates ranging from 5–13% [3-6].
ADHD is the most common psychiatric disorder in chil-
dren and is diagnosed in males two to nine times as often
as in females. ADHD shows high comorbidity with several
other conditions including learning differences, opposi-
tional defiance disorder (ODD), obsessive compulsive
disorder (OCD) and depression [7,8] For up to 60% of
these children, ADHD symptoms and difficulties will per-
sist into adulthood [9,10].
The cause of ADHD is generally acknowledged to be mul-
tifactorial, involving both biological and environmental
influence [2,11]. In the past two decades, there has been
an increasing focus particularly on the effects of diet in
hyperactivity in children. Researchers have reported that
various aspects of a child's diet including food additives,
refined sugars, food allergies, minerals and fatty acid
metabolism may have adverse effects on behav-
iour[7,12,13]. While there is no definitive proof that any
of these is responsible for the spectrum of ADHD symp-
toms, there is a compelling argument for a role for long-
chain polyunsaturated fatty acids.
The processes of elongation and desaturation occur
mainly in the liver, but also in the central nervous system,
placenta, glial tissue and choroid plexus vasculature[14].
Within the brain, four fatty acids are particularly impor-
tant; dihomogammalinolenic acid (20:3n-6, DGLA), ara-
chidonic acid (20:4n-6, AA), eicosapentaenoic acid
(20:5n-3, EPA) and docosahexaenoic acid (22:6n-3). AA
and DHA play a major structural role in neuronal mem-
branes and make up 20% of the dry mass of the brain[11].
In addition the eicosanoid and other fatty acid metabo-
lites of various LC-PUFAs, though at much lower concen-
trations, could play important roles in brain function [15-
19]. EPA and DGLA play a more minor structural role but
are also crucial for normal brain function. Since optimal
requirements are not fully known, definitive dietary refer-
ence intakes (DRIs) for the omega-3 and omega-6 fatty
acids have not yet been determined[20]. However, Petrie
and colleagues published recommendations for adequate
intake (AI) for boys 9–16 yr as 12–16 g linoleic acid (LA)/
d and 1.2–1.6 g α-linolenic acid (ALA)/d. For girls the cor-
responding amounts were 10–11 LA g/d and 1.0–1.1 ALA
g/d[21]. In order to ensure the best biological functions,
Bjerve suggests an intake of 900 mg/d EPA and 400 mg/d
DHA[22].
A number of the physical and behavioural symptoms of
essential fatty acid deficiency mimic some of the symp-
toms described in typical ADHA patients, therefore it is
conceivable, that either dietary deficiency of omega-3 fatty
acids, or altered metabolic handling of these fatty acids,
could contribute to the abnormalities observed in those
affected by ADHD. Several studies have examined fatty
acid status in patients with ADHD, but only recently have
researchers begun to examine efficacy of high dose supple-
mentation on ADHD behaviours [13,23-25].
The purpose of the present study was to compare several
parameters in an adolescent ADHD population versus an
adolescent control population. Parameters included com-
parisons of dietary patterns between the groups based on
7-day diet records and analysis of red blood cell fatty acid
composition and serum hormone levels as well as the fre-
quency of symptoms of fatty acid deficiency and ADHD-
associated behaviours in both populations.
Experimental methods
Subject selection
This study was approved by the Research Ethics Board at
the University of Guelph.
Adolescent males and females aged ten to sixteen years
were recruited from the City of Guelph and surrounding
area starting in March 2004 via flyers and local advertise-
ments. Approximately 45 parents and/or subjects con-
tacted the study coordinator for further information
regarding the study protocol. Of these, 23 subjects and
their families agreed to participate and gave informed
consent. The main reason for declining to participate was
a result of the child or adolescent's refusal to have blood
taken.
In all there were 11 subjects with a confirmed physician
diagnosis of ADHD according to DSM-IV criterion and 12
control subjects without a diagnosis of ADHD that acted
as participants. One subject in the control group com-
pleted study visit #1 before dropping out of the study due
to lack of interest and three subjects in the control group
participated in a single visit, condensed study protocol,
due to time constraints. The remaining 19 subjects partic-
ipated in the entire protocol.
Experimental protocol
All study visits occurred at the Human Nutraceutical
Research Unit. All subject visits were scheduled in advance
via email or telephone and occurred on weekday morn-
ings between the hours of 7 and 11 am. Study visits for
male and pre-menstrual female subjects were coordinated
on the basis of convenience for the participants. Study vis-
its for female subjects who had begun menstruation were
coordinated to occur on or as close menstrual cycle day 5.
It was mandatory that a parent or guardian be on campus
with the subject for visit one. All subjects were required to
fast for a period of at least 8 h prior to study visits and
were allowed to consume water only during this period.Nutrition Journal 2008, 7:8 http://www.nutritionj.com/content/7/1/8
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Study visit #1
Following introductions, the subject and guardian were
invited to sit with the study coordinator to go through
experimental details and protocols and sign a consent
form. Following this, a Subject Health Questionnaire and
Conners' Parent Rating Scale (CPRS:L) were explained
and presented to the guardian for completion. During this
visit, a variety of baseline measurements were taken for
each subject. Height (without shoes) was measured in
centimeters (cm) and weight (kg) in light clothing
recorded (Acculab SV-100, Haverhill, MA). Following a 5
min rest period, blood pressure and pulse were measured
using a battery operated portable machine (Lifesource,
Milpitas, CA) and were recorded in systole over diastole
and beats per minute (bpm), respectively. Next, body
composition was estimated using bioelectrical impedance
analysis (BIA, BodyStat 1500, British Isles). Following
body composition measures, a fasting venous blood sam-
ple was taken for further analysis (four untreated, four in
heparinized tubes, Vacutainer, Becton Dickinson, NJ).
Following blood collection, subjects were provided with
unlimited beverages and a small breakfast.
The purpose and protocol for the completion of the 7-day
dietary record was then explained to both the subjects and
their guardians. Subjects were instructed to keep their
usual dietary habits and the importance of accurate com-
pletion was stressed. Subjects were given a study package
to take home with them, which included 5 two-sided die-
tary record sheets, written explanation and details of how
to complete them, and reference sheets for common food
sizes. Before leaving a tentative return date was scheduled
for 4–6 weeks later.
Behaviour assessment
The revised Conners' Parent Rating Scale long version
(CPRS-R:L) was administered during visit #1 of the study
for all subjects and completed by the attending parent or
guardian. Assessment of 80 common problems was based
on the child's behaviour in the preceding month and they
were asked to circle the best answer for each item. All par-
ent-rating scores were converted to T-scores through the
use of the CPRS:L sheet for score profiling. The scale was
used to assess not only ADHD, but also problems with
conduct, cognition, family relationships, emotional
issues, anger management, and/or anxiety.
Study visit #2
Four to six weeks following the first visit, a second study
visit was coordinated. Subjects were required to fast for a
period of at least 8 hours as with visit one, and the four
tubes of blood were taken as close to arrival time as possi-
ble. Subjects were again provided with a snack following
blood collection. Following this, the dietary record sheets
were collected and the distribution and access to the study
results were explained to all subjects and their guardian.
Prior to departure, the subject was presented with a $25
gift certificate for participation. Subjects who participated
in the condensed study protocol, which included one visit
only, were presented with a $15 gift certificate. All study
visits occurred between June 2004 and August 2005.
Diet analysis
All subjects recorded their daily diet consumption for
seven consecutive days between study visit 1 and 2. On
study visit 2 these pages were submitted to the investiga-
tor. Diet analysis was performed using the computer-
based program Food Processor©  (Version 7.11, ESHA
Research, Oregon). All food and beverage items ingested
over the seven day period were entered into the program,
and nutrition values were averaged to a per day basis.
Blood analysis
Following collection, the red top tubes were placed at
room temperature for at least 15 min to allow clotting.
Heparinized tubes were immediately placed on ice. All
tubes were centrifuged for 20 min at 500 × g. The serum
and plasma fractions were collected by pipette and depos-
ited into labeled aliquot tubes for storage. Red blood cell
fractions were prepared following removal of plasma and
white blood cells from sodium heparinized samples and
tubes were filled to the top with 0.9% sodium chloride
saline solution (Abbott Laboratories Ltd., Quebec). The
contents were mixed well by inversion and the tube was
then centrifuged for 20 min at 500 × g. Following this
wash, the upper saline layer was discarded and the red
blood cell fraction was collected and pipetted into labeled
aliquot tubes. All aliquot tubes were stored at -20 degrees
for a maximum of 5 days and were then transferred to a -
80 freezer until analysis.
Red blood cell fatty acid analysis
Following chloroform:methanol extraction, phospholip-
ids were separated from other lipids my thin layer chro-
matography and methylated fatty acids determined by an
outside commercial laboratory (Lipid Analytical Labora-
tories, Guelph, ON). Fatty acids were measured in RBC
blood samples from both study visits 1 and 2, when avail-
able, and values were averaged for the purpose of statisti-
cal analyses. Fatty acid values are presented as percentage
of molecular weight.
Statistical Analysis
Statistical significance was accepted at p < 0.05, using a
two-tailed test. All statistical analysis was performed using
SPSS 10.0 for Windows Student Version. Statistical analy-
ses performed included independent samples t-test for
means comparisons and bi-variate Pearson's correlations.
Data is reported as mean ± standard deviation (SD), and
in some cases, followed by the range of values in paren-Nutrition Journal 2008, 7:8 http://www.nutritionj.com/content/7/1/8
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theses. All data were normally distributed and the differ-
ences in SDs between groups were not significantly
different.
Results
Subject characteristics at visit #1 are given in Table 1.
There were no significant differences between the groups
for age and sex characteristics or anthropometric meas-
ures. A health questionnaire was filled out at the start of
the study by the parent/guardian for each subject. The
questionnaire collected information regarding ADHD
diagnosis, medication use, co-morbid disorders/condi-
tions, vitamin/supplement use, family history of ADHD,
allergies, duration of breastfeeding and prevalence of fatty
acid deficiency symptoms. Six of eleven subjects in the
ADHD group were taking medications (55%), five of
eleven presented with a co-morbid learning disorder
(45%), and eight of eleven reported a history of ADHD
within the family (73%). These three variables were signif-
icantly different from the control group with p = 0.016, p
= 0.016 and p = 0.001, respectively.
The duration of breastfeeding in infancy was also
reported. Subjects in the ADHD group were breastfed an
average of 4.14 ± 2.6 (0–7) months, whereas subjects in
the control group were breastfeed an average of 10.4 ±
10.9 (3–39) months. With respect to symptoms of fatty
acid deficiency, subjects in the ADHD group reported an
average of 2.4 ± 3.5 (0–9) symptoms versus 1.6 ± 1.6 (0–
4) symptoms in the control group. Neither of these differ-
ences between groups was significant (p = 0.077 and p =
0.461, respectively).
The ADHD group was also more likely to have allergies
(27% vs. 8%) and less likely to be taking vitamins (18%
vs. 50%) when compared to the control group. Again, nei-
ther of these differences were significant.
Behaviour assessment
Analysis of the Conners' Parent Rating Scales Long Ver-
sion (CPRS:L) revealed several significant differences
between the ADHD and control groups (Table 2). When
compared to the control group, the ADHD group pre-
sented with significantly higher mean T scores on ten of
the fourteen scales included in the assessment (p < 0.05)
(Figure 1). These included measures for oppositional
behaviours, cognitive problems and inattention, restless-
ness and impulsivity, hyperactivity, emotional lability
and overall problematic behaviour. Children were also
identified as 'at risk' through scores on the ADHD index,
while also being assessed on scales directly related to
DSM-IV criteria including inattentive, hyperactive-impul-
sive and total DSM scores.
Diet analysis
Analysis of seven-day dietary records from subjects
(ADHD n = 11, Control n = 8) revealed several differences
between intake patterns (Table 3, not all data is shown).
The ADHD group consumed significantly more calories
(2652 ± 458 vs. 2051 ± 407, p = 0.009), more protein (91
± 19 g vs. 73 ± 17 g, p = 0.049) and more carbohydrates
(357 ± 68 g vs. 271 ± 60 g, p = 0.011) per day when com-
pared to the control group. The ADHD group also con-
sumed significantly more total fat (99 ± 22 g vs. 77 ± 14 g,
p = 0.013), saturated fats (38 ± 9 g vs. 28 ± 8 g, p = 0.027)
and trans fatty acids (3.6 ± 3.1 g vs. 1.3 ± 0.7 g, p = 0.038)
per day. There was also a trend toward higher monoun-
saturated fat consumption in the ADHD group (31 ± 9 g
vs. 24 ± 6 g), however this difference was not significance
(p = 0.077). There were no significant differences in mean
consumption of total n-3 fatty acids, ALA, EPA or DHA
between the two groups. Furthermore, there were no dif-
ferences in mean consumption of total n-6 fatty acids, LA
or AA. Calculated n-6: n-3 ratios revealed values of 9.47 in
the ADHD group and 9.03 in the control group. These
ratios were not significantly different from one another.
Table 1: Baseline subject characteristics and anthopometric measurements
ADHD Group (n = 11) Control Group (n = 12)
Variable Mean ± SD Mean ± SD
Sex, n male/female 9/2 6/6
Age, years ± SD 13.6 ± 2.2 14.2 ± 1.9
Age range, years 10.4–16.4 11.3–16.6
Height (cm) 163.5 ± 12.2 160.5 ± 8.4
Weight (kg) 52.7 ± 15.5 49.5 ± 12.2
BMI (kg/m2) 19.3 ± 3.8 19.0 ± 3.2
Lean weight (kg) 43.6 ± 16.4 38.3 ± 8.4
% lean mass 80.6 77.7
Fat weight (kg) 9.1 ± 3.6 11.2 ± 4.8
% fat mass 19.4 22.3
Systolic blood pressure (mmHg) 107.0 ± 17.7 109.6 ± 9.7
Diastolic blood pressure (mmHg) 66.6 ± 8.2 66.5 ± 7.1
Heart Rate (bpm) 66.5 ± 8.7 72.8 ± 14.4Nutrition Journal 2008, 7:8 http://www.nutritionj.com/content/7/1/8
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The ADHD group consumed significantly greater
amounts of vitamin B1 (1.84 ± 0.34 mg vs. 1.42 ± 0.37
mg), vitamin B2 (2.34 ± 0.70 mg vs. 1.54 ± 0.36 mg), iron
(21.66 ± 7.04 mg vs. 12.52 ± 3.43 mg) and sodium (4001
± 931 mg vs. 3119 ± 756 mg) in their diets when com-
pared to controls (p < 0.05). There were also trends
toward increased calcium and zinc intake in the ADHD
group when compared to the control group however,
these differences were not significant.
Pearson correlations between diet variables and CPRS:L
scale rating revealed several positive and significant rela-
tionships. Total energy intake was positively correlated
with scores for oppositional and hyperactive behaviours
(p < 0.01), in addition to restlessness, problematic behav-
iour and DSM-IV total (p < 0.05). Saturated fat and total
fat intakes displayed a significant positive correlation to
scales measuring oppositional, hyperactive (Figure 2) and
problematic behaviours (p < 0.01), as well as DSM-IV
total score (p < 0.05). Iron intake was also positively cor-
related with the cognitive problem, DSM-IV inattentive,
DSM-IV total (Figure 3), problematic behaviour and rest-
lessness scales (p < 0.01), in addition to the oppositional,
hyperactivity and ADHD index scales (p < 0.05). Finally,
intake of sodium was positively correlated with the hyper-
activity and restlessness scales (p < 0.01), and with the
oppositional, problematic behaviour, ADHD index, DSM
inattentive and DSM total scales (p < 0.05).
Fatty acid analysis
Phospholipid analysis of red blood cell samples was per-
formed and all fatty acids were reported as a mol percent-
age of total membrane fatty acids (Table 4, not all data is
shown). When compared to controls, the ADHD group
presented with significantly lower DHA (3.12 ± 0.75 vs.
4.39 ± 1.34, p = 0.012) and total n-3 fatty acids (5.79 ±
1.39 vs. 7.42 ± 1.64, p = 0.018). The ratio of n-3 fatty acids
to n-6 fatty acids was also significantly lower in the ADHD
group (0.17 ± 0.04 vs. 0.23 ± 0.06, p = 0.017). The ADHD
group also presented with elevated LA (13.26 ± 0.95 vs.
12.02 ± 2.14), total n-6 (33.33 ± 1.83 vs. 32.51 ± 1.59)
and total saturated fatty acid levels when compared to the
Conners' Parent Rating Scale (CPRS:L) mean T scores (with  mean standard error) for ADHD group versus controls Figure 1
Conners' Parent Rating Scale (CPRS:L) mean T 
scores (with mean standard error) for ADHD group 
versus controls. CPRS:L scales; A: Oppositional, B: Cogni-
tive Problems/Inattention, C: Hyperactivity, D: Anxious-Shy, 
E: Perfectionism, F: Social Problems, G: Psychosomatic, H: 
Conners' ADHD Index, I: CGI Restlessness-Impulsive, J: CGI 
Emotional Lability, K: CGI Total, L: DSM-IV Inattentive, M: 
DSM-IV Hyperactive-Impulsive, N: DSM-IV Total. ADHD 
group presented with significantly higher mean raw scores on 
Scales A-C and H-N, for a total of 10/14 scales. Significantly 
different from control group ** p < 0.01, * p < 0.04.
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Table 2: Behaviour Assessment Data
Conners' Rating ADHD Group (n = 11) Control Group (n = 12)
Scale: Measurement Mean T Score ± SD (range) Mean T Score ± SD (range)
A: Oppositional 66.6 ± 15.8 (44–90) * 53.8 ± 8.3 (39–66)
B: Cognitive Problems/Inattention 68.0 ± 9.7 (56–84) ** 50.1 ± 7.5 (43–66)
C: Hyperactivity 73.8 ± 12.8 (49–90) ** 53.8 ± 10.6 (44–77)
D: Anxious-Shy 59.8 ± 17.6 (42–90) 58.3 ± 14.4 (42–90)
E: Perfectionism 51.9 ± 14.5 (40–82) 51.6 ± 9.9 (41–70)
F: Social Problems 67.4 ± 15.7 (45–90) 56.9 ± 16.8 (45–90)
G: Psychosomatic 59.6 ± 14.7 (42–90) 57.9 ± 13.4 (42–83)
H: Conners' ADHD Index 73.2 ± 10.6 (55–90) ** 51.2 ± 10.8 (42–79)
I: CGI Restless-Impulsive 74.7 ± 11.7 (54–89) ** 52.4 ± 8.6 (43–70)
J: CGI Emotional Lability 64.1 ± 19.5 (42–90) * 49.3 ± 7.9 (41–65)
K: CGI Total 72.6 ± 13.5 (51–90) ** 51.8 ± 9.1 (42–69)
L: DSM-IV Inattentive 71.6 ± 10.0 (58–90) ** 50.7 ± 7.8 (43–69)
M: DSM-IV Hyperactive-Impulsive 76.0 ± 14.1 (48–90) ** 53.7 ± 10.8 (43–71)
N: DSM-IV Total 76.2 ± 11.3 (55–90) ** 52.1 ± 9.0 (42–70)
Significantly different from control subjects ** p < 0.01, * p < 0.04Nutrition Journal 2008, 7:8 http://www.nutritionj.com/content/7/1/8
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control group however; none of these latter differences
were significant.
Analysis of the relationship between red blood cell con-
tent and diet variables identified multiple significant cor-
relations. Total caloric intake was positively correlated
with total n-6 red blood cell content (r = .451, p = 0.026)
and negatively correlated with DHA (r = -.491, p = 0.016),
total n-3 (r = -.509, p = 0.013) and the n-3: n-6 ratio (r = -
.544, p = 0.008). Similarly, total dietary fat intake was pos-
itively correlated with total n-6 red blood cell content (r =
.552, p = 0.007) (Figure 4) and negatively correlated with
Scatterplot of dietary iron intake (y-axis) and mean raw  score on Conners' DSM-IV total scale (x-axis) Figure 3
Scatterplot of dietary iron intake (y-axis) and mean 
raw score on Conners' DSM-IV total scale (x-axis). 
Significant positive correlation r = .496, p = 0.015.
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Table 3: Diet Record Analysis Data
Dietary Variable ADHD Group (n = 11) Control Group (n = 8) p value
Total Energy (kcal) 2651.0 ± 458.1 * 2051.4 ± 407.0 0.009
Protein (g) 90.9 ± 19.0 * 73.0 ± 17.0 0.049
Carbohydrates (g) 356.9 ± 68.1 * 271.1 ± 59.6 0.011
Total Fat (g) 99.4 ± 21.8 * 76.7 ± 13.6 0.013
Saturated Fat (g) 38.1 ± 9.1 * 28.3 ± 8.2 0.027
Monounsaturated Fat (g) 30.9 ± 8.6 24.1 ± 6.4 NS
Polyunsaturated Fat (g) 10.8 ± 4.0 9.7 ± 4.3 NS
Total omega-3 (g) 0.72 ± 0.31 0.76 ± 0.37 NS
Alpha Linolenic Acid (g) 0.66 ± 0.28 0.71 ± 0.36 NS
Eicosapentaenoic Acid (mg) 22 ± 54 14 ± 17 NS
Docosahexaenoic Acid (mg) 31 ± 53 39 ± 47 NS
Total omega-6 (g) 6.82 ± 3.79 6.86 ± 3.85 NS
Linoleic Acid (g) 6.78 ± 3.79 6.81 ± 3.84 NS
Arachidonic Acid (mg) 38 ± 19 51 ± 35 NS
omega-6: omega 3 9.47 9.03 NS
Vitamin B1 (mg) 1.8 ± 0.3 * 1.4 ± 0.4 0.019
Vitamin B2 (mg) 2.3 ± 0.7 * 1.5 ± 0.4 0.01
Iron (mg) 21.7 ± 7.0 * 12.5 ± 3.4 0.002
Sodium (mg) 4001 ± 931* 3119 ± 755 0.042
Calcium (mg) 1050 ± 282 798 ± 239 NS
Zinc (mg) 13 ± 5 9 ± 3 NS
Data represents daily consumption as averaged from 7-day diet records. Values are reported as mean ± SD. * Significantly different from control 
group (p < 0.05)
Scatterplot of dietary fat intake (y-axis) and mean raw score  on Conners' hyperactivity scale (x-axis) Figure 2
Scatterplot of dietary fat intake (y-axis) and mean 
raw score on Conners' hyperactivity scale (x-axis). 
Significant positive correlation r = .606, p = 0.003.
Conners' Scale C_Hyperactivity
100 90 80 70 60 50 40
D
i
e
t
a
r
y
 
F
a
t
 
I
n
t
a
k
e
-
 
T
o
t
a
l
 
(
g
)
130
120
110
100
90
80
70
60Nutrition Journal 2008, 7:8 http://www.nutritionj.com/content/7/1/8
Page 7 of 11
(page number not for citation purposes)
DHA (r = -.532, p = 0.010), total n-3 (r = -.570, p = 0.005)
(Figure 5) and the n-3: n-6 ratio (r = -.609, p = 0.003). Sat-
urated fat and sodium intakes displayed similar trends
with respect to correlation to blood fatty acid parameters.
There were several significant correlations between spe-
cific red blood cell parameters and Conners' scale ratings.
Red blood cell DHA content was negatively correlated
with scale ratings for oppositional behaviour, hyperactiv-
ity, cognitive problems, restlessness, problematic behav-
iour, DSM-IV inattention and DSM-IV total (p < 0.05)
(Figure 6). Total n-3 content was negatively correlated
with the Conners' scale for restlessness (p < 0.05) and the
n-3: n-6 ratio was negatively related to the oppositional,
restlessness and problematic behaviour scales (p < 0.05).
Finally, total red blood cell n-6 content was positively cor-
related with the oppositional, restlessness, problematic
behaviour, DSM-IV inattentive, DSM-IV total and ADHD
index scales (p < 0.05).
Discussion
Most clinical studies have focused on fatty acid and other
abnormalities associated with ADHD in children (6–12
years) and adult populations (18–65 years) [25-28]. One
recent study used a slightly older population where the
average age of subjects was 11 years [24]and in the current
study our subjects had a mean age of 14 years. The pri-
mary objective of this study was to determine whether
abnormalities typically observed in younger and older
Scatterplot of red blood cell total n-6 content (y-axis) and  dietary fat intake (x-axis) Figure 4
Scatterplot of red blood cell total n-6 content (y-axis) 
and dietary fat intake (x-axis). Significant positive 
correlation r = .552, p = 0.007.
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Table 4: Red Blood Cell Fatty Acid Analysis Data
ADHD (n = 11) Control (n = 12)
Total omega-3 Fatty Acids 5.79 ± 1.39 † 7.42 ± 1.64
Alpha-Linolenic Acid (18:3 n-3) 0.16 ± 0.07 0.13 ± 0.09
Stearidonic Acid (18:4 n-3) 0.07 ± 0.04 0.07 ± 0.04
20:3 n-3 0.02 ± 0.01 0.02 ± 0.01
Eicosatetraenoic Acid (20:4 n-3) 0.05 ± 0.05 0.05 ± 0.04
Eicosapentaenoic Acid (20:5 n-3) 0.51 ± 0.21 0.64 ± 0.24
Docosapentaenoic Acid (22:5 n-3) 1.88 ± 0.71 2.03 ± 0.56
Docosahexaenoic Acid (22:6 n-3) 3.12 ± 0.75 † 4.39 ± 1.34
Total omega-6 Fatty Acids 33.33 ± 1.83 32.51 ± 1.59
Linoleic Acid (18:2 n-6) 13.26 ± 0.95 * 12.02 ± 2.14
Gamma-Linolenic Acid (18:3 n-6) 0.05 ± 0.03 0.06 ± 0.03
Eicosadienoic Acid (20:2 n-6) 0.15 ± 0.07 0.14 ± 0.09
Dihomo-gamma-linolenic Acid (20:3 n-6) 1.69 ± 0.20 * 1.84 ± 0.51
Arachidonic Acid (20:4 n-6) 14.51 ± 1.67 14.73 ± 1.48
Docosadienoic Acid (22:2 n-6) 0.05 ± 0.03 0.04 ± 0.06
Adrenic Acid (22:4 n-6) 3.61 ± 1.33 3.63 ± 0.72
Docosapentanoic Acid (22:5 n-6) 0.03 ± 0.03 0.07 ± 0.01
n-3: n-6 Ratio 0.17 ± 0.04 † 0.23 ± 0.06
n-6: n-3 Ratio 5.86 ± 2.04 * 4.64 ± 1.27
AA/EPA 31.61 ± 8.91 26.04 ± 10.27
Total Saturated Fatty Acids 39.38 ± 1.79 39.26 ± 1.16
Total Monounsaturated Fatty Acids 21.51 ± 1.15 20.81 ± 1.15
Total Polyunsaturated Fatty Acids 39.11 ± 2.48 39.93 ± 1.76
Values are means +/- standard deviation and given as a mol % of total fatty acids. † Significant difference between groups (p < 0.02), * Difference 
between groups (p = 0.095)Nutrition Journal 2008, 7:8 http://www.nutritionj.com/content/7/1/8
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populations are also observed in adolescents with ADHD
when compared to controls.
The Conners' Parent Rating Scale (CPRS:L) was utilized
for behaviour assessment in this study. The CPRS:L is well
respected and has been used widely among studies assess-
ing ADHD behaviours in children [28-32]. The Conners'
scale used provides an appropriate instrument for measur-
ing behaviours in youths aged 3 to 17 and conveys infor-
mation that corresponds to the official ADHD criteria in
the DSM-IV [33]. In general, T-scores of 65 and above are
usually taken to indicate a clinically significant problem.
In this study, the ADHD group presented with signifi-
cantly higher mean T-scores than the control group on ten
of the fourteen scales on the CPRS:L. This significant dif-
ference was expected as individuals were assigned to the
ADHD group based on whether or not they had been pre-
viously diagnosed by a physician as having the disorder. It
is interesting to note however, that the mean T-scores for
the ADHD group did not reach 65 or above on 4 of the 14
measures. Furthermore, there were subjects within the
ADHD group who did not present with 65 or higher on
any of the scales. Perhaps, these particular individuals
have become better able to cope with their symptoms over
time, which contributed to the presence of less problem-
atic behaviours. It is also possible that some of these indi-
viduals were misdiagnosed with ADHD or "grew out of
it". Regardless, had these potentially misdiagnosed indi-
viduals not been in the ADHD group here, it is possible
that there may have been more significant differences
between the groups. There were also subjects in the con-
trol group who had multiple scales with T-scores of 65 or
more. To this effect, one subject in the control group pre-
sented with T-scores greater than 65 on 11 of 14 scales, the
fifth most out of all 23 subjects in the study. This same
individual was subsequently diagnosed with ADHD
shortly after this study ended. As such, all of the data relat-
ing to this subject was transferred to the ADHD data pool.
As a group, the ADHD subjects in this study presented
with mean T-scores that are comparable to other studies
[27-32], although slightly higher on most scales. The
higher T-scores in the current study may simply reflect the
fact that similar behaviours in a nine-year old would be
given a much higher T score, if exhibited by a 13-year old.
The behaviour assessment performed here identified that
the ADHD group had higher mean T-scores than controls
on over seventy-five percent of the Conners' scales, indi-
cating that problematic behaviours persist into adoles-
cence for the majority of these individuals. The Conners'
Parent Rating Scale appears to be an extremely reliable
tool when comparing ADHD behaviours among individ-
uals of different gender and age.
The red blood cell phospholipid fatty acid composition
data reported here, indicates that adolescent ADHD sub-
jects have lower total omega-3 fatty acids, lower DHA lev-
els and higher linoleic acid levels when compared to age-
matched control subjects. The absolute values and degree
of difference between groups are similar to those reported
elsewhere in studies of younger children and adults with
and without ADHD[12,30,32,34] However, we did not
see several differences reported by Stevens, which
included lower AA and adrenic acid levels, and higher
docosapentaenoic acid levels in ADHD subjects when
compared to controls[29]. Stevens did report lower DHA
levels in the ADHD group but this was not statistically sig-
nificant in their study[29]. In 2004, Chen and colleagues
reported significantly lower levels of AA, LA, DHA and
total n-3 in red blood cell phospholipids of young chil-
dren with ADHD when compared to controls[12]. Simi-
larly, when fatty acid composition of red blood cells were
compared in an adult population, Young and her col-
leagues reported significantly lower DHA and signifi-
cantly higher total n-6 fatty acids among other measures,
in the individuals with ADHD[34]. Thus, while there are
some differences in the specific fatty acid changes, the data
we report here for adolescents indicates that childhood
patterns persist through adolescence and into adulthood
with few alterations. In several other studies, authors have
reported higher AA/EPA ratios in subjects with ADHD. In
our study there was a numerical difference but this was
not statistically different; a larger sample size may have
been able to pick up this difference as the standard devia-
tion for this estimate was quite large. If indeed the levels
of AA and EPA are not different between groups, this
would suggest that delta-5 desaturase activity may be nor-
mal in the ADHD subjects. Rather, the fact that DHA lev-
els were significantly lower in ADHD subjects may suggest
a higher rate of oxidation of this fatty acid in these
patients. None-the-less, a lower level of circulating DHA
may indicate lower levels in the brain as well.
Two previous studies reported dietary patterns in children
with ADHD using three day diet records[12,29]. Using a
complete seven day diet record, we examined the intake
patterns of our adolescent subjects. We demonstrate that
ADHD subjects consumed higher levels of at least 10 dif-
ferent nutrients, than their control counterparts. This
included 25% more energy, and more grams of carbohy-
drate, total fat, omega-6 fatty acids and trans fatty acids in
addition to others. Stevens reported significantly higher
intakes of total fat (g) and polyunsaturated fatty acids (g)
in ADHD subjects when compared to control sub-
jects[29]. In 2004, Chen and colleagues reported signifi-
cantly increased iron (mg) and vitamin C (mg)
consumption in subjects with ADHD versus controls[12].
As has been previously proposed, it is possible that over-
ingestion of fats could interfere with the conversion ofNutrition Journal 2008, 7:8 http://www.nutritionj.com/content/7/1/8
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parent essential fatty acids (EFAs) to long-chain(LC)-
PUFAs[11]. Despite the many dietary differences between
our subject groups, they did not differ in either total
omega-3 fatty acid consumption, or consumption of the
LC-PUFAs. Thus, it is unlikely that dietary differences in
omega-3 consumption can explain the significant differ-
ences in red blood cell membrane fatty acids observed in
the ADHD subjects herein.
Whatever the reason for lower levels of DHA in ADHD
subjects, or abnormal LC-PUFA status, an important ques-
tion is whether this pattern can be normalized through
dietary intervention or supplementation. Early supple-
mentation trials with modest levels (eg. 300–500 mg
DHA/day) of LC-PUFAs were largely neutral or showed
only modest improvement in biochemical or behavioural
parameters in ADHD subjects[27,28,35,36]. However,
two recent studies using very high levels of long chain
omega-3 PUFAs suggest that the plasma fatty acid abnor-
malities can be reversed and that there may be significant
impact on behavioural parameters [24,25]. Germano and
coworkers examined the effects of 0.23 g/kg body weight/
day, fish-oil distillate containing a 2:1 ratio of EPA:DHA
in 16 ADHD and 31 control children after an 8-week sup-
plementation period[25]. The ADHD group had a signifi-
cantly higher AA:EPA ratio than the controls at time zero
and the supplementation decreased both ratios substan-
tially so that there was no difference between the groups
after 8 weeks supplementation. They also reported signif-
icant improvements in Inattention and Hyperactivity
using the Conner's short-version inventory [25]. Sorgi and
colleagues examined the effects of a high dose (initially
16.2 g) EPA/DHA concentrate on nine ADHD children
over 8 weeks with dosage adjustment at week 4 depending
on AA:EPA ratio [24]. They showed a similar, dramatic
decrease in the AA:EPA ratio in the subjects and improve-
ments using the ADHD Symptom Checklist 4, and the
short version of the Conners' Parents Rating Scale{Sorgi,
2007 2845/id. These two latest studies suggest that fatty
acid supplementation at high levels may be necessary to
normalize blood fatty acids, and by assumption brain
fatty acids, to achieve improvements in ADHD sympto-
mology. Clearly additional large scale interventions are
now warranted.
Regardless of diagnosis in the current study, dietary fat
intake was significantly and positively correlated with
scores on five of the Conners' scales, positively correlated
with total n-6 red blood cell content and negatively corre-
lated with total n-3 red blood cell content. Also, as Chen
and colleagues have reported, there was a significantly
higher intake of iron in the ADHD group [12]. In the
present study, iron intake also displayed a significant and
positive correlation to scores on eight of the Conners'
scales. It is possible that iron levels in children and adoles-
cents have an effect on behaviours and should therefore
be investigated in future studies. Reports have also indi-
cated that children with ADHD may be deficient in mag-
nesium [7,37]. However, in the present study, ADHD
subjects reported slightly higher (but not significant)
intakes of magnesium when compared to controls. Previ-
ous research had also suggested lower intakes of tyrosine,
tryptophan and phenylalanine in individuals with ADHD
compared to controls[38] however, this was not the case
Scatterplot of red blood cell DHA content (y-axis) and Con- ners' DSM-IV total score (x-axis) Figure 6
Scatterplot of red blood cell DHA content (y-axis) 
and Conners' DSM-IV total score (x-axis). Significant 
negative correlation r = -.378, p = 0.037.
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Scatterplot of red blood cell total n-3 content (y-axis) and  dietary fat intake Figure 5
Scatterplot of red blood cell total n-3 content (y-axis) 
and dietary fat intake. Significant negative correla-
tion r = -.570, p = 0.005.
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in the current study where again, if anything intakes for
these amino acids were higher in ADHD subjects. From
these data, a clear role for minerals and amino acids in
ADHD behaviours can not be established and will require
further investigation.
Conclusion
This study investigated differences between adolescent
populations with and without ADHD with respect to a
variety of measures. Despite the small sample size and an
imbalance of genders within the groups, several signifi-
cant differences were reported with respect to overall
health, dietary patterns and red blood cell fatty acid com-
positions. Adolescents with ADHD appear to consume
diets more rich in total energy, in addition to specific fats,
minerals and other constituents. Although there was no
difference in the dietary consumption of n-3 or n-6 fatty
acids, adolescents with ADHD did present with signifi-
cantly lower levels of DHA, total n-3 fatty acids and a
lower n-3: n-6 ratio in red blood cell phospholipids.
Abnormalites in fatty acid profile were also positively cor-
related with higher ratings on the Conner's scales. Further
research is required to determine the mechanisms by
which these fatty acid anomalies occur, and whether
indeed supplementation for extended periods with high
concentrations of omega-3 fatty acids will positively influ-
ence ADHD behaviours in patients of all ages.
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